SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-097801
Filing Date
2012-03-06
Accepted
2012-03-06 06:52:53
Documents
3
Period of Report
2012-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d311276d8k.htm 8-K 13046
2 PRESS RELEASE d311276dex991.htm EX-99.1 71834
3 GRAPHIC g311276ex99_1logo.jpg GRAPHIC 18302
  Complete submission text file 0001193125-12-097801.txt   111481
Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34921 | Film No.: 12668759
SIC: 2834 Pharmaceutical Preparations